Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China flag China · Delayed Price · Currency is CNY
6.52
-0.23 (-3.41%)
Apr 30, 2026, 9:55 AM CST

Beijing SL Pharmaceutical Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2017
Cash & Equivalents
519.4411.96683.83595.04827.84
Upgrade
Short-Term Investments
-1,089840.62713.36646.23
Upgrade
Trading Asset Securities
498.95480.86608.56144.91162.36
Upgrade
Cash & Short-Term Investments
1,0181,9822,1331,4531,636
Upgrade
Cash Growth
-48.63%-7.07%46.77%-11.19%13.41%
Upgrade
Accounts Receivable
80.93105.79200.57254.86357.56
Upgrade
Other Receivables
14.0715.6535.2531.3521.6
Upgrade
Receivables
95121.44235.82286.2379.16
Upgrade
Inventory
681.81246.33144.46136.82124.83
Upgrade
Other Current Assets
298.8138.8126.69121.34157.31
Upgrade
Total Current Assets
2,0942,4892,6401,9982,298
Upgrade
Property, Plant & Equipment
541.53514.24503.34527.3604.01
Upgrade
Long-Term Investments
1,5731,5781,5731,7981,404
Upgrade
Other Intangible Assets
633.01678.58693.77526.36479.46
Upgrade
Long-Term Deferred Tax Assets
53.769.52-39.527.65
Upgrade
Long-Term Deferred Charges
503.88519451.89454.42394.72
Upgrade
Other Long-Term Assets
673.25130.49415.6532.22553.25
Upgrade
Total Assets
6,0725,9796,2785,8765,760
Upgrade
Accounts Payable
95.54122.29250.76176.18191.4
Upgrade
Accrued Expenses
46.4845.8246.9330.3231.8
Upgrade
Current Portion of Leases
----0.25
Upgrade
Current Income Taxes Payable
2.440.1802.614.48
Upgrade
Current Unearned Revenue
491.9670.5315.2927.8713.33
Upgrade
Other Current Liabilities
93.1750.5960.3451.8583.71
Upgrade
Total Current Liabilities
729.59289.41373.33288.83324.96
Upgrade
Long-Term Leases
----2.22
Upgrade
Long-Term Unearned Revenue
41.074447.0451.3856.23
Upgrade
Long-Term Deferred Tax Liabilities
112.8364.9747.3656.3950.82
Upgrade
Total Liabilities
883.49398.37467.72396.6434.23
Upgrade
Common Stock
1,0271,0271,0271,0271,027
Upgrade
Additional Paid-In Capital
61.5549.6249.6243.8532.58
Upgrade
Retained Earnings
4,1144,4824,7104,3964,265
Upgrade
Comprehensive Income & Other
-21.7713.4713.470.67-12.99
Upgrade
Total Common Equity
5,1815,5725,8015,4685,311
Upgrade
Minority Interest
7.198.29.4211.1614.73
Upgrade
Shareholders' Equity
5,1895,5815,8105,4795,326
Upgrade
Total Liabilities & Equity
6,0725,9796,2785,8765,760
Upgrade
Total Debt
----2.47
Upgrade
Net Cash (Debt)
1,0181,9822,1331,4531,634
Upgrade
Net Cash Growth
-48.63%-7.07%46.77%-11.06%13.67%
Upgrade
Net Cash Per Share
1.001.872.101.431.57
Upgrade
Filing Date Shares Outstanding
1,0021,0271,0271,0271,027
Upgrade
Total Common Shares Outstanding
1,0021,0271,0271,0271,027
Upgrade
Working Capital
1,3642,1992,2671,7091,973
Upgrade
Book Value Per Share
5.175.425.655.325.17
Upgrade
Tangible Book Value
4,5484,8945,1074,9424,832
Upgrade
Tangible Book Value Per Share
4.544.764.974.814.70
Upgrade
Buildings
-434.54437.22430.73452.32
Upgrade
Machinery
-472.98458.48435.39415.76
Upgrade
Construction In Progress
-94.9256.9764.7599.87
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.